Siqi Liu
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.
Journal: Cardiovascular diabetology
Published: September 23, 2025
Association between metabolic syndrome, fatty liver disease, and gastrointestinal tumors: a population-based study with external validation.
Journal: Frontiers in nutrition
Published: September 17, 2025
Elevated ascitic interleukin-36 receptor antagonist mediates CD8+T cell exhaustion in vitro in liver cirrhotic patients with spontaneous bacterial peritonitis.
Journal: Immunology letters
Published: March 10, 2025
The neutrophil-lymphocyte ratio as a risk factor for all-cause mortality among individuals with resolved HBV infection: evidence from the NHANES 1999-2018.
Journal: Frontiers in public health
Published: September 09, 2024
Investigation of circulating natural autoantibodies against ANXA1 and MYC as potential biomarkers in hepatocellular carcinoma.
Journal: Advances in medical sciences
Published: June 08, 2024
Research progress on short-term prognosis of acute-on-chronic liver failure.
Journal: Expert review of gastroenterology & hepatology
Published: January 04, 2023
Interleukin-35 dampens T helper 22 phenotype shift in CD4+CD25+CD127dim/- regulatory T cells in primary biliary cholangitis.
Journal: International immunopharmacology
Published: December 14, 2022
Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis.
Journal: Biomolecules & biomedicine
Published: September 17, 2022
Overexpression of ascitic interleukin-35 induces CD8+ T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis.
Journal: International immunopharmacology
Published: January 19, 2022
Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Journal: International immunopharmacology
Published: August 05, 2021
The Mechanism of Interleukin-35 in Chronic Hepatitis B.
Journal: Seminars in liver disease
Published: July 07, 2021
Last Updated: 09/26/2026